col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


14 Results       Page 1

 [1] 
AME Publishing Company: Translational Lung Cancer Research
  original article Date Title Authors   All Authors
1 [GO] 2025―May―29 Impact of coronavirus disease 2019 on surgery in patients with early-stage lung cancer: the COVIDLungSurg prospective cohort study Zhenyi Niu, Feng Zhu, Yuqin Cao, Congcong Luo, Dan Liu, Chunping Wang, et al. (+23)
2 [GO] 2023―Jul―27 First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemic Suganija Lakkunarajah, Pauline T. Truong, Jeffrey N. Bone, Curtis Hughesman, Stephen Yip, Deepu Alex, et al. (+6)
3 [GO] 2022―Jun―17 Shift in lung cancer stage at diagnosis during the COVID-19 pandemic in New York City Raja Flores, Naomi Alpert, Ken McCardle, Emanuela Taioli
4 [GO] 2022―Feb―28 How SOLID is the immune system’s response to the deadly duo of lung cancer and SARS-CoV-2? Hiba Narvel, Balazs Halmos
5 [GO] 2022―Feb―25 One more piece to SOLIDify our knowledge on the impact of SARS-CoV-2 in patients with cancer Alfredo Addeo, Alessio Cortellini, Giuseppe Luigi Banna
6 [GO] 2021―Dec―20 Assessment of the fear of COVID-19 and its impact on lung cancer screening participation among the Korean general population Thuy Linh Duong, Nayoung Lee, Yonghyun Kim, Yeol Kim
7 [GO] 2021―Dec―13 Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study Mariano Provencio, Delvys Rodríguez-Abreu, Ana L. Ortega, Gloria Serrano, Carlos Aguado, Fernando Franco, et al. (+34)
8 [GO] 2021―Apr―29 Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen Anna Pous, Cristina Izquierdo, Marc Cucurull, Silvia Sánchez, Clara Lezcano, Marta Domenech, et al. (+3)
9 [GO] 2021―Jan―26 Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues Francesca Casaluce, Cesare Gridelli
10 [GO] 2020―Oct―28 A narrative review of lung cancer cytology in the times of coronavirus: what physicians should know Pasquale Pisapia, Umberto Malapelle, Maria Salatiello, Rafael Rosell, Giancarlo Troncone
11 [GO] 2020―Aug―28 COVID-19 and early-stage lung cancer both featuring ground-glass opacities: a propensity score-matched study Ya-Jie Zhang, Wen-Jie Yang, Dong Liu, Yu-Qin Cao, Yu-Yan Zheng, Yi-Chao Han, et al. (+30)
12 [GO] 2020―Aug―28 Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients Paul Hofman
13 [GO] 2020―Aug―28 Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer Rafael Rosell, Niki Karachaliou, Sara Fancelli, Oscar Arrieta, Giancarlo Troncone, Peng Cao
14 [GO] 2020―Apr―30 Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19 Haoyue Guo, Xiaoxia Chen, Chunxia Su, Yu Liu, Hao Wang, Chenglong Sun, et al. (+20)
 [1] 

14 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec